These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
272 related articles for article (PubMed ID: 29248392)
1. Targeting Human Immunodeficiency Virus Pre-Exposure Prophylaxis to Adolescent Sexual Minority Males in Higher Prevalence Areas of the United States: A Modeling Study. Goodreau SM; Hamilton DT; Jenness SM; Sullivan PS; Valencia RK; Wang LY; Dunville RL; Barrios LC; Rosenberg ES J Adolesc Health; 2018 Mar; 62(3):311-319. PubMed ID: 29248392 [TBL] [Abstract][Full Text] [Related]
2. Modeling the Impact of PrEP Programs for Adolescent Sexual Minority Males Based on Empirical Estimates for the PrEP Continuum of Care. Hamilton DT; Rosenberg ES; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Aslam M; Mustanski B; Goodreau SM J Adolesc Health; 2021 Mar; 68(3):488-496. PubMed ID: 32798099 [TBL] [Abstract][Full Text] [Related]
3. Potential Impact of HIV Preexposure Prophylaxis Among Black and White Adolescent Sexual Minority Males. Hamilton DT; Goodreau SM; Jenness SM; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Rosenberg ES Am J Public Health; 2018 Nov; 108(S4):S284-S291. PubMed ID: 30383415 [TBL] [Abstract][Full Text] [Related]
4. Cost-Effectiveness of Pre-Exposure Prophylaxis Among Adolescent Sexual Minority Males. Wang LY; Hamilton DT; Rosenberg ES; Aslam MV; Sullivan PS; Katz DA; Dunville RL; Barrios LC; Goodreau SM J Adolesc Health; 2020 Jan; 66(1):100-106. PubMed ID: 31757626 [TBL] [Abstract][Full Text] [Related]
5. Impact of the Centers for Disease Control's HIV Preexposure Prophylaxis Guidelines for Men Who Have Sex With Men in the United States. Jenness SM; Goodreau SM; Rosenberg E; Beylerian EN; Hoover KW; Smith DK; Sullivan P J Infect Dis; 2016 Dec; 214(12):1800-1807. PubMed ID: 27418048 [TBL] [Abstract][Full Text] [Related]
6. Improving the impact of HIV pre-exposure prophylaxis implementation in small urban centers among men who have sex with men: An agent-based modelling study. Gantenberg JR; King M; Montgomery MC; Galárraga O; Prosperi M; Chan PA; Marshall BDL PLoS One; 2018; 13(7):e0199915. PubMed ID: 29985949 [TBL] [Abstract][Full Text] [Related]
7. Modeling the joint effects of adolescent and adult PrEP for sexual minority males in the United States. Hamilton DT; Rosenberg ES; Jenness SM; Sullivan PS; Wang LY; Dunville RL; Barrios LC; Aslam M; Goodreau SM PLoS One; 2019; 14(5):e0217315. PubMed ID: 31116802 [TBL] [Abstract][Full Text] [Related]
8. Potential impact of pre-exposure prophylaxis for female sex workers and men who have sex with men in Bangalore, India: a mathematical modelling study. Mitchell KM; Prudden HJ; Washington R; Isac S; Rajaram SP; Foss AM; Terris-Prestholt F; Boily MC; Vickerman P J Int AIDS Soc; 2016; 19(1):20942. PubMed ID: 27609782 [TBL] [Abstract][Full Text] [Related]
9. Incidence of Gonorrhea and Chlamydia Following Human Immunodeficiency Virus Preexposure Prophylaxis Among Men Who Have Sex With Men: A Modeling Study. Jenness SM; Weiss KM; Goodreau SM; Gift T; Chesson H; Hoover KW; Smith DK; Liu AY; Sullivan PS; Rosenberg ES Clin Infect Dis; 2017 Sep; 65(5):712-718. PubMed ID: 28505240 [TBL] [Abstract][Full Text] [Related]
10. Projected Impact of Concurrently Available Long-Acting Injectable and Daily-Oral Human Immunodeficiency Virus Preexposure Prophylaxis: A Mathematical Model. Maloney KM; Le Guillou A; Driggers RA; Sarkar S; Anderson EJ; Malik AA; Jenness SM J Infect Dis; 2021 Jan; 223(1):72-82. PubMed ID: 32882043 [TBL] [Abstract][Full Text] [Related]
11. Gonorrhoea and chlamydia diagnosis as an entry point for HIV pre-exposure prophylaxis: a modelling study. Kasaie P; Schumacher CM; Jennings JM; Berry SA; Tuddenham SA; Shah MS; Rosenberg ES; Hoover KW; Gift TL; Chesson H; German D; Dowdy DW BMJ Open; 2019 Mar; 9(3):e023453. PubMed ID: 30837248 [TBL] [Abstract][Full Text] [Related]
12. Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort study. Grulich AE; Guy R; Amin J; Jin F; Selvey C; Holden J; Schmidt HA; Zablotska I; Price K; Whittaker B; Chant K; Cooper C; McGill S; Telfer B; Yeung B; Levitt G; Ogilvie EE; Dharan NJ; Hammoud MA; Vaccher S; Watchirs-Smith L; McNulty A; Smith DJ; Allen DM; Baker D; Bloch M; Bopage RI; Brown K; Carr A; Carmody CJ; Collins KL; Finlayson R; Foster R; Jackson EY; Lewis DA; Lusk J; O'Connor CC; Ryder N; Vlahakis E; Read P; Cooper DA; Lancet HIV; 2018 Nov; 5(11):e629-e637. PubMed ID: 30343026 [TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study. Molina JM; Charreau I; Spire B; Cotte L; Chas J; Capitant C; Tremblay C; Rojas-Castro D; Cua E; Pasquet A; Bernaud C; Pintado C; Delaugerre C; Sagaon-Teyssier L; Mestre SL; Chidiac C; Pialoux G; Ponscarme D; Fonsart J; Thompson D; Wainberg MA; Doré V; Meyer L; Lancet HIV; 2017 Sep; 4(9):e402-e410. PubMed ID: 28747274 [TBL] [Abstract][Full Text] [Related]
14. Individual HIV Risk versus Population Impact of Risk Compensation after HIV Preexposure Prophylaxis Initiation among Men Who Have Sex with Men. Jenness SM; Sharma A; Goodreau SM; Rosenberg ES; Weiss KM; Hoover KW; Smith DK; Sullivan P PLoS One; 2017; 12(1):e0169484. PubMed ID: 28060881 [TBL] [Abstract][Full Text] [Related]
15. Elimination prospects of the Dutch HIV epidemic among men who have sex with men in the era of preexposure prophylaxis. Rozhnova G; Heijne J; Bezemer D; van Sighem A; Presanis A; De Angelis D; Kretzschmar M AIDS; 2018 Nov; 32(17):2615-2623. PubMed ID: 30379687 [TBL] [Abstract][Full Text] [Related]
16. Targeting pre-exposure prophylaxis among men who have sex with men in the United States and Peru: partnership types, contact rates, and sexual role. Carnegie NB; Goodreau SM; Liu A; Vittinghoff E; Sanchez J; Lama JR; Buchbinder S J Acquir Immune Defic Syndr; 2015 May; 69(1):119-25. PubMed ID: 25942463 [TBL] [Abstract][Full Text] [Related]
17. A Cost-effectiveness Analysis of Preexposure Prophylaxis for the Prevention of HIV Among Los Angeles County Men Who Have Sex With Men. Drabo EF; Hay JW; Vardavas R; Wagner ZR; Sood N Clin Infect Dis; 2016 Dec; 63(11):1495-1504. PubMed ID: 27558571 [TBL] [Abstract][Full Text] [Related]
18. Willingness to Take, Use of, and Indications for Pre-exposure Prophylaxis Among Men Who Have Sex With Men-20 US Cities, 2014. Hoots BE; Finlayson T; Nerlander L; Paz-Bailey G; Clin Infect Dis; 2016 Sep; 63(5):672-7. PubMed ID: 27282710 [TBL] [Abstract][Full Text] [Related]
19. Sexual Risk Behaviors in Adolescent Sexual Minority Males: A Systematic Review and Meta-Analysis. Valencia R; Wang LY; Dunville R; Sharma A; Sanchez T; Rosenberg E J Prim Prev; 2018 Dec; 39(6):619-645. PubMed ID: 30446869 [TBL] [Abstract][Full Text] [Related]
20. Rates of Pre-exposure Prophylaxis Use and Discontinuation Among a Large U.S. National Sample of Sexual Minority Men and Adolescents. Whitfield THF; Parsons JT; Rendina HJ Arch Sex Behav; 2020 Jan; 49(1):103-112. PubMed ID: 31845148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]